82791-70-6

Basic information

• Product Name: Propanamide, N-[4-(hydroxyphenylmethyl)-3-pyridinyl]-2,2-dimethyl-
• CAS NO: 82791-70-6
• Molecular Formula: C17H20N2O2
• Molecular Weight: 284.358
• Mol File: 82791-70-6.mol

Chemical Properties

• CAS DataBase Reference: Propanamide, N-[4-(hydroxyphenylmethyl)-3-pyridinyl]-2,2-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Propanamide, N-[4-(hydroxyphenylmethyl)-3-pyridinyl]-2,2-dimethyl-(82791-70-6)
• EPA Substance Registry System: Propanamide, N-[4-(hydroxyphenylmethyl)-3-pyridinyl]-2,2-dimethyl-(82791-70-6)

Safety Data

• Hazardous Substances Data: 82791-70-6(Hazardous Substances Data)

Upstream product

• 3282-30-2 pivaloyl chloride 
• 462-08-8 pyridin-3-ylamine 
• 70298-88-3 N-(pyridin-3-yl)pivalamide 
• 100-52-7 benzaldehyde 

Downstream Products

• 125867-45-0 10-phenyl-6,7,8,9-terahydrobenzo<1,7>naphtyridine 
• 125867-42-7 4-phenyl-1,2-dihydropyrido<3,4-d>-2-pyrimidinone 
• 3810-18-2 1,3-dihydro-5-phenyl-2H-pyrido<3,4-e>-1,4-diazepin-2-one 
• 15505-59-6 3-benzyloxycarbonylaminomethylcarbonylamino-4-benzoylpyridine 
• 112175-42-5 3-tert-butoxycarbonylaminomethylcarbonylamino-4-benzoylpyridine 
• 112175-39-0 1,3-dihydro-1-methyl-5-phenyl-2H-pyrido<3,4-e>-1,4-diazepin-2-one 
• 3810-11-5 (3-aminopyridin-4-yl)(phenyl)methanone 
• 112175-38-9 N-(4-benzoylpyridin-3-yl)-2,2-dimethylpropionamide 

Relevant articles and documents

Quinolinones as Inhibitors of Translation Initiation Complex

Provided herein are compounds and pharmaceutical compositions comprising quinolinones. The quinolinones and compositions thereof are useful as eukaryotic translation initiation factor 4F (eIF4F) complex modulators.

PROTEIN KINASE INHIBITORS

The present invention provides a compound incorporating a group of formula (I) wherein: 1 of X, Y and Z is nitrogen and the other 2 are carbon; V is sulpur or carbon; R3 is oxygen or fluorine; R4 is an optionally present C1-3 alkyl group optionally substituted by fluorine; R5 is an optionally present cyclic group with 5-7 heavy atoms in the ring which may be carbocyclic or heterocyclic and aromatic or aliphatic and is optionally substituted, e.g. by a halogen, C1-2 alkyl or fluoroalkyl, OH, OR6, cyano, COOR6, CONHR6, sulfonamide or NHR6, in which R6 is a C1-2 alkyl or fluoroalkyl; at least one of R4 and R5 is present and R4 and R5 may both be present; m and n are each 1 or 2 depending on the identity of V and R3; when n=2 each R3 may be the same or different but are preferably the same, when m=2, each R4 and each R5 may be the same or different but are preferably the same; and W represents hydrogen, carbon, nitrogen, oxygen or sulphur; or incorporating a salt, hydrate or solvate of a group of formula (I); as well as therapeutic uses of these compounds, in particular as inhibitors of protein kinase activity and in the treatment of inflammation, inflammatory conditions and cancer.

Design, synthesis, and structure-activity relationships of aminopyridine N-oxides, a novel scaffold for the potent and selective inhibition of p38 mitogen activated protein kinase

A novel series of aminopyridine N-oxides were designed, synthesized, and tested for their ability to inhibit p38α MAP kinase. Some of these compounds showed a significant reduction in the LPS-induced TNFR production in human whole blood. Structure-activit

Synthesis of aza analogues of the anticancer agent batracylin

Three series of pyrido-fused pyrimido[2,1-a]isoindol-7-ones were prepared from readily available (aminopyridinyl)(aryl)methanones by reduction followed by a Mitsunobu reaction with phthalimide and acid-catalysed cyclodehydration. This approach provides a wide variety of aza analogues of the antitumour agent batracylin.

Synthesis of ortho-substituted aminopyridines. Metalation of pivaloylamino derivatives

The three isomeric pivaloylaminopyridines were lithiated in more than 80% yields. Aminopyridine derivatives were treated by 2.5-3 equivalents of the complex BuLi-TMEDA at -10° in diethyl ether. Reaction of the lithiated species with various electrophiles afforded a number of ortho-substituted pivaloylaminopyridines in good yields. Secondary pyridine alcohols were oxidized to the corresponding aminopyridyl ketones. Pyridopyrimidines, benzonaphthyridines as well as an analogue of the natural antitumor alkaloid ellipticine has been synthesized showing the versatility of the method.

Regiospecific Electrophilic Substitution of Aminopyridines: Ortho Lithiation of 2-, 3-, and 4-(Pivaloylamino)pyridines

2- and 4-(pivaloylamino)pyridines have been shown to undergo metalation exclusively at C-3 and these smoothly react with a variety of electrophiles to produce 2,3- and 3,4-disubstituted pyridines, respectively.Removal of the pivaloyl protecting group results in overall electrophilic substitution of an aminopyridine.Utilization of this method is exemplified by efficient syntheses of 2- and 4-aminonicotinaldehydes.Minor modifications of the reaction conditions permitted exclusive ortho metalation of 2-(pivaloylamino)pyridines additionally functionalized by chloro, fluoro, or methyl groups.Although the major product from reaction of 3-(pivaloylamino)pyridine by this method was metalation at C-4, the reaction was complicated by substantial quantities of product derived from nucleophilic attack by n-butyllithium on the pyridine nucleus.